Financial Times FT.com

Resources

Investing in Israel

Investing in Israel report

● Interview: Stanley Fischer, governor of the Bank of Israel
● Biotech: An increasingly vital sector
● Outsourcing: Strength in cultural ties - -

Content

‘As good as it gets’

The economy is doing well, writes Sharmila Devi.

Stock markets: US and UK play an important funding role

Nasdaq and Aim are popular exchanges, many companies are also listed in Tel Aviv and some are looking east, writes Sharmila Devi.

Capital markets: Opening to outside influences

Recent reforms should widen choice and increase competitiveness, writes Sharmila Devi.

Economy: Welcome boost to confidence

Sharmila Devi talks to Stanley Fischer, who became governor of the Bank of Israel last year.

Venture capital: Competition increases as market opens

The sector owes its existence to government intervention, but is coming of age as foreign groups join in, explains Sharmila Devi.

Biotech: Life sciences on a global stage

Sharmila Devi on an increasingly vital sector.

Profile: ‘Free telephony is the tip of the iceberg’

Kayote Networks is a leader in VoIP, writes Harvey Morris.

Real estate: Property prices stage recovery

The lull in violence is helping drive the market as foreign investors take a serious interest, writes Sharmila Devi.

Outsourcing: Unique selling point

Israel can offer clients unrivalled cultural links, says Sharmila Devi.

Profile: Fresh hope for leukaemia sufferers

Gamida Cell is a world leader in technology using stem cells extracted from blood, reports Sharmila Devi.